In 2022, Germitec received investments from Financière Arbevel, Kurma Partners, via its Kurma Growth Opportunities fund, and Sham Innovation Santé advised by Turenne Capital, become GERMITEC in preparation for its global commercial launch and to expand into the U.S. market. Germitec has its headquarters in Bordeaux and is building their team for global commercialization and additional pipeline products. Germitec is hiring its Head of Global Distribution.
We have partnered with Sébastien Lemoine, Chief Business Officer, to hire our Head of Global Distribution. This position will manage all distribution channels in Europe, Middle East, and eventually APAC regions. Our Head of Global Distribution will evaluate current distributors, support our key markets, and source alternative partners and must have B2B experience selling medical devices directly to hospital systems.
Germitec UV-C high level disinfection technology is leading the way in chemical free and ultrafast automated high level disinfection for reprocessing ultrasound probes. Our technology works by delivering UV-C High Level Disinfection (HLD) as particles and waves reflected from the chamber walls. Its chemical free operation safeguards staff and patients by avoiding hazardous chemicals, fumes, and spills. When seconds count, Germitec systems, Chronos and AE1, deliver a Faster, Simpler and Cleaner solution that reduces cross-infection risk, for a seamless High Level Disinfection. Thus improving quality patient care.
CEO and Board Member
Chief Business Officer
Lifeblood™ supports global MedTech Startups with Talent Acquisition and Fundraising Strategies. We build full-scale startup teams from Board and C-level executives to entry-level individual contributors and from early-stage R&D through multi-national commercialization phases.Approaching two decades of experience in the MedTech industry, our talent acquisition services and team-building efforts are the results of 2,000+ successful hires for 500+ companies in 6 continents. We have facilitated more than $220 million for MedTech startups with our fundraising strategies and global investor network.
People and money are the lifeblood capital of startups. Learn from our entrepreneurs and investors as we demystify raising and investing capital on our MedTech Money Podcast Series.